Missing/wrong data?
Log in to edit
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia
scientific article published on 22 April 2009
Author/s
author: Kalifa A Bojang, Paul J. Milligan, Margaret Pinder, W Ripley Ballou, Opokua Ofori-Anyinam, Marc Lievens
Work details
Publication date
April 22, 2009
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.